Table 1.
Baseline characteristics of the myocarditis patients
Characteristics | myocarditis group | DCM group |
---|---|---|
Number | 30 | 30 |
Demography | ||
Age (year) | 29.2 ± 8.7 | 31.4 ± 6.8 |
Male (%) | 21 (70%) | 15 (50%) |
Body-mass index | 26.8 ± 9.5 | 28.2 ± 6.5 |
Clinical characteristics | ||
Diagnosis to transplantation (months) | 18.0 ± 6.3 | 22.0 ± 11.4 |
SBP (mmHg) | 102.3 ± 21.2 | 114.7 ± 15.9 |
Heart rate | 92 ± 21 | 103 ± 19 |
Medication history | ||
Antiplatelet (%) | 12 (40%) | 9 (30%) |
Digoxin (%) | 24 (80%) | 21 (70%) |
ACEI/ARB (%) | 15 (50%) | 12 (40%) |
Diuretic (%) | 30 (100%) | 30 (100%) |
Beta blockers (%) | 27 (90%) | 24 (60%) |
Antiarrhythmic (%) | 21 (70%) | 12 (40%) |
Cardiac function | ||
Ⅰ (%) | 0 | 0 |
Ⅱ (%) | 3 (10%) | 0 |
Ⅲ (%) | 9 (30%) | 3 (10%) |
Ⅳ (%) | 18 (60%) | 27 (90%) |
Hypertension | 9 (30%) | 6 (20%) |
Diabetes | 0 | 0 |
hyperlipidemia | 6 (20%) | 9 (30%) |
ECG | ||
AF | 12 (40%) | 9 (30%) |
LBBB | 12 (40%) | 3 (10%) |
RBBB | 9 (30%) | 6 (20%) |
Paroxysmal ventricular tachycardia | 6 (20%) | 12 (40%) |
UCG | ||
left atrium diameter (mm) | 51.2 ± 9.4 | 54.6 ± 12.5 |
LVEDD (mm) | 62.8 ± 10.2 | 63.5 ± 14.3 |
EF (%) | 37.6 ± 10.4 | 29.3 ± 9.8 |
Moderately to severe MR (%) | 15 (50%) | 21 (70%) |
ECG: electrocardiogram; AF: atrial fibrillation; LBBB: left bundle branch block; RBBB: right bundle branch block; LVEDD: Left ventricular end diastolic diameter; EF: Ejection fraction; MR: Mitral regurgitation.